Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2013
08/21/2013CN103261418A Bispecific aptamers mediating tumour cell lysis
08/21/2013CN103261413A Marker for determination of sensitivity to triplet combination anti-cancer agent
08/21/2013CN103261412A Antihuman CCR7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-mmobilized carrier
08/21/2013CN103261399A Composition for preventing inflammations
08/21/2013CN103261209A Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
08/21/2013CN103261203A 6-amido derivatives of 4,5a-poxymorphinans for treatment of pain
08/21/2013CN103261202A Fused tricyclic compounds as adenosine receptor antagonist
08/21/2013CN103261201A 2-amino-4-arylthiazole compounds as TRPA1 antagonists
08/21/2013CN103261200A Purine compounds as prodrugs of a2b adenosine receptor antagonists, their process and medicinal applications
08/21/2013CN103261199A Naphthyridine derivative
08/21/2013CN103261198A 2-arylimidazo[1,2-]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives
08/21/2013CN103261197A Highly-soluble pyrroloquinoline quinone salt and method for producing same
08/21/2013CN103261196A Pyrazolopyridines as inhibitors of the kinase lrrk2
08/21/2013CN103261195A 1,2,4-triazolo[4,3-]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
08/21/2013CN103261194A Oxazolyl-methylether derivatives as ALX receptor agonists
08/21/2013CN103261193A Oxadiazole inhibitors of leukotriene production
08/21/2013CN103261192A 5-methyl-1-(naphthalen--yl)-1h-pyrazole derivatives and their use in potentiating the effect of opioid analgesics
08/21/2013CN103261190A Novel benzofurane compounds
08/21/2013CN103261189A Amino-pyrrolidine-zetidine diamides as monoacylglycerol lipase inhibitors
08/21/2013CN103261187A Process for preparing tetrazole-ubstituted anthranilamide derivatives and novel crystal polymorph of these derivatives
08/21/2013CN103261186A Dimeric IAP inhibitors
08/21/2013CN103261185A Continuous arycyclic compound
08/21/2013CN103261169A Deubiquitinase inhibitors and methods for use of the same
08/21/2013CN103261167A Substituted 6,6-used nitrogenous heterocyclic compounds and uses thereof
08/21/2013CN103261165A 胰高血糖素受体调节剂 Glucagon receptor modulators
08/21/2013CN103261163A Novel multicomponent crystals made of ([2-mino-6-(4-fluoro-benzylamino)- pyridin-3-yl]- carbamic acid ethyl ester and an arylpropionic acid
08/21/2013CN103261162A Novel multicomponent crystals made of ([2-mino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and 2-2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid
08/21/2013CN103261161A Crystalline forms of a factor Xa inhibitor
08/21/2013CN103261160A Guanidine compounds and compositions for the inhibition of nampt
08/21/2013CN103261156A New compounds for the treatment of neurodegenerative diseases
08/21/2013CN103261138A Halogenated biphenols as antibacterial agents
08/21/2013CN103260703A Piperidin-4-yl-zetidine diamides as monoacylglycerol lipase inhibitors
08/21/2013CN103260629A Composition for use in treating and preventing inflammation related disorder
08/21/2013CN103260628A Use of hyaluronan for promoting angiogenesis
08/21/2013CN103260627A Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd).
08/21/2013CN103260626A Conjugate for photodynamic diagnosis or therapy and method for preparing same
08/21/2013CN103260625A Ibat inhibitors for the treatment of liver diseases
08/21/2013CN103260624A Use of laquinimod for reducing fatigue, improving functional status, and improving quality of life in multiple sclerosis patients
08/21/2013CN103260623A Bepotastine compositions
08/21/2013CN103260622A Novel fused pyridine compounds as casein kinase inhibitors
08/21/2013CN103260621A Topical localized isoxazoline formulation
08/21/2013CN103260620A Topical localized isoxazoline formulation comprising glycofurol
08/21/2013CN103260619A Treatment of cognitive disorders with certain alpha- nicotinic acid receptor agonists in combination with acetylcholinesterase inhibitors
08/21/2013CN103260618A Inhibitor of activity of endothelin, and skin whitening agent
08/21/2013CN103260617A Novel pharmaceutical formulation comprising NSAID and cyclodextrin
08/21/2013CN103260616A Stabilizer of acetaminophen
08/21/2013CN103260615A Low dose pharmaceutical composition
08/21/2013CN103260614A Combination therapy
08/21/2013CN103260613A 3-methanesulfonylpropionitrile for treating inflammation and pain
08/21/2013CN103260612A Treatment of mecp2-ssociated disorders
08/21/2013CN103260610A Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain ?
08/21/2013CN103260607A Process for the preparation of a PPI-containing pharmaceutical product
08/21/2013CN103260606A Compositions and methods for cardiac therapy
08/21/2013CN103260406A Methods for the preparation of charged crosslinkers
08/21/2013CN103260402A Antimicrobial polyether and polyol compounds
08/21/2013CN103257189A (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use
08/21/2013CN103255206A Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
08/21/2013CN103255187A Low molecular hyaluronate, preparation method and purpose thereof
08/21/2013CN103255076A Bacillus spp and hyaluronidase and preparation method and purpose thereof
08/21/2013CN103255075A Pantoea ananatis which generates exopolysaccharide and extraction and usage of polysaccharide thereof
08/21/2013CN103255061A Penicillium griseofulvum, antibacterial active compound generated thereby and application
08/21/2013CN103254448A Medical sodium hyaluronate gel and preparation method thereof
08/21/2013CN103254321A Method for extracting and purifying Phellinus vaninii polysaccharides of medicinal fungus Phellinus vaninii
08/21/2013CN103254279A Polypeptide conjugate of paclitaxel or docetaxel
08/21/2013CN103254269A A,B-cyclobilactam steroid compound and synthetic method thereof and application A,B-cyclobilactam steroid compound of in preparing antitumor drugs
08/21/2013CN103254267A Novel forms of cddo methyl ester
08/21/2013CN103254266A Steroid zinc metal complex and preparation method thereof as well as application of complex in preparation of antitumor medicines
08/21/2013CN103254264A Pregnenolone aromatic aldehydes azine steroid compound and synthetic method thereof as well as application of compound in preparation of antitumor medicines
08/21/2013CN103254263A Cardiac glycoside compound and preparation method as well as application thereof
08/21/2013CN103254259A Iridoid glycoside compound as well as preparation method and application thereof
08/21/2013CN103254256A Application of arbutin sugar ester derivative in preparation of cosmetics or drugs
08/21/2013CN103254239A aryl ruthenium-beta-carboline complex and its preparation method and application
08/21/2013CN103254223A Silicon phthalocyanine axially modified by aminoethyl phenoxyl and polyethylene glycol oligomer
08/21/2013CN103254212A Annonaceous acetogenins derivatives, and preparation method and purpose thereof
08/21/2013CN103254207A Compound with antihypertensive activity and preparation method thereof
08/21/2013CN103254205A Spirocyclic derivatives as histone deacetylase inhibitors
08/21/2013CN103254203A Five-membered urea ring-coumarin derivative or pharmaceutical salt and application thereof
08/21/2013CN103254193A 黄嘌呤类化合物中间体及其制备方法 Xanthine compound intermediates and preparation method
08/21/2013CN103254191A Substituted aryl tetracyclic antifungal compound as well as preparation method and application thereof
08/21/2013CN103254190A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
08/21/2013CN103254184A 5-substituted-3-[5-hydroxy-4-pyrone-2-yl-methylmercapto]-4-amino-1,2,4-triazole compound and application thereof
08/21/2013CN103254177A Modulators of atp-binding cassette transporters
08/21/2013CN103254176A Salt of trachycladindole A derivative
08/21/2013CN103254174A Lansoprazole compound and pharmaceutical composition thereof
08/21/2013CN103254172A Cytoskeletal active rho kinase inhibitor compounds, composition and use
08/21/2013CN103254155A Tetrahydropyrrole derivative and preparation method thereof
08/21/2013CN103254151A Benzisoxa thiazoles 5-LOX and mPGES-1 inhibitor and application
08/21/2013CN103254143A 4-[4-(2-diethylamino acetamido)phenylamino]-6-(substituted methoxyl)formylamino quinazoline compound as well as preparation method and application thereof
08/21/2013CN103254142A 4-[4-(2-subtituted amino acetylamino)phenylamino] quinazoline derivative as well as preparation method and application thereof
08/21/2013CN103254130A Acridine derivative and preparation method and application thereof
08/21/2013CN103254129A Intergrase inhibitor
08/21/2013CN103254127A Glycine-reuptake inhibitor and application thereof
08/21/2013CN103254126A Deuterated omega-diphenyl carbamide as well as derivative and pharmaceutical composition including compounds
08/21/2013CN103254120A Spiro-azasugar quaternary ammonium salt compound, and preparation method and application thereof
08/21/2013CN103254119A Inhibitors of sodium glucose co-transporter 2 and methods of their use
08/21/2013CN103254114A Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment
08/21/2013CN103254088A Tapentadol hydrochloride crystal form D as well as preparation method and application thereof
08/21/2013CN103254086A Aromatic ester 5-LOX and mPGES-1 inhibitor and application
08/21/2013CN103254081A Cancer pain therapeutic drug
08/21/2013CN103254080A Pain therapeutic drug
1 ... 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 ... 7860